Упрощенная HTML-версия
283
213.
Hutyrova B.
Interleukin-1 gene cluster polymorphisms in sarcoidosis and
idiopathic pulmonary fibrosis / B. Hutyrova, P. Pantelidis, J. Drabek, M. Zurkova,
V. Kolek, K. Lenhart, K.I. Welsh, R.M. Du Bois, M. Petrek // Am. J. Respir. Crit.
Care Med. – 2002. – Vol. 165. – P. 148-151.
214.
Ibrahim E.H. A comparative analysis of patients with early-onset vs late -
onset nosocomial pneumonia in the ICU setting / E.H. Ibrahim, S. Ward, G.
Sherman // Chest. – 2000. – Vol. 117. – Р. 1434-1442.
215.
Experience with a clinical guideline for the treatment of ventilator-associated
pneumonia / E.H. Ibragim [et al.] // Crit. Care Med. - 2001. - Vol. 29. - P. 1109-
1115.
216.
Clinical importance of delays in the initiation of appropriate antibiotic
therapy / M. Iregui [et al.] // Chest. – 2002. – Vol. 122. – P. 262-268.
217.
Isakow W. Methicillin-resistant Staphylococcus aureus pneumonia – current
and future therapeutic options / W. Isakow, M. Pharm // US Respiratory Disease. –
2006. - Is. II. – P. 62-64.
218.
Polymorphism in the promoter of lipopolysaccharide receptor CD14 and
ischemic cerebrovascular disease / D. Ito [et al.] // Stroke. – 2000. – Vol. 31. – P.
2661-2664.
219.
Jaber S.
Cytomegalovirus infection in critically III patients. Associated
factors and consequences / S. Jaber, G. Chanques, J. Borry, B. Souche, R. Verdier,
P.-F. Perrigault, J.-J. Eledjam // Chest. – 2005. – Vol. 127. – P. 233-241.
220.
Jeffres M.N
.
Predictors of mortality for methicillin-resistant Staphylococcus
aureus health-care-associated pneumonia / M.N. Jeffres, W. Isakow, J.A. Doherty,
P.S. McKinnon, D.J. Ritchie, S.T. Micek, M.H. Kollef // Chest. – 2006. – Vol.
130. – P. 947-955.
221.
Jessen K.M. Common TNF-α, IL-1β, PAI-1, uPA, CD14 and TLR4
polymorphisms are not associated with disease severity or outcome from gram
negative sepsis / K.M. Jessen, S.B. Lindboe, A.L. Petersen, J. Eugen-Olsen, T.
Benfield // BMC Infectious Diseases. – 2007. – Vol. 7 (108). – P. 1-7.